We are live on !
Find out more
Aperio Group Portfolio holdings
AUM
$33.8B
Turnover
6.32%
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$33.8B
AUM Growth
+$4.19B
(+14%)
Cap. Flow
+$264M
Cap. Flow % of AUM
Cap. Flow %
0.78%
Top 10 Holdings %
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53
Avg Time Held
4.6
years
Top 10 Avg Time Held
3.4
years
Top 20 Avg Time Held
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$52.4M |
| 2 |
Tesla
TSLA
|
+$42.1M |
| 3 |
Microsoft
MSFT
|
+$16.9M |
| 4 |
Walt Disney
DIS
|
+$14.5M |
| 5 |
Morgan Stanley
MS
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever NV New York Registry Shares
UN
|
+$48.8M |
| 2 |
AT&T
T
|
+$25.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$20M |
| 4 |
Amazon
AMZN
|
+$15.7M |
| 5 |
Biogen
BIIB
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.68% |
| 2 | Financials | 13.75% |
| 3 | Healthcare | 13.35% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1151
Globus Medical
GMED
$10.9B
| $2.4M | 0.01% |
36,852
+1,346
| +4% | +$77.4K |
2016 Q4
16 quarters
|
|
1152
WesBanco
WSBC
$3.75B
| $2.4M | 0.01% |
80,208
-1,562
| -2% | -$42.2K |
2017 Q1
15 quarters
|
|
1153
Rogers Corp
ROG
$2.23B
| $2.39M | 0.01% |
15,373
-40
| -0.3% | -$5.3K |
2016 Q1
19 quarters
|
|
1154
Semtech
SMTC
$12.3B
| $2.38M | 0.01% |
33,031
+7,322
| +28% | +$468K |
2016 Q1
19 quarters
|
|
1155
DELISTED
Big Lots, Inc.
BIG
| $2.37M | 0.01% |
55,290
-1,050
| -2% | -$51K |
2014 Q2
26 quarters
|
|
1156
DELISTED
Hanesbrands
HBI
| $2.37M | 0.01% |
162,673
-1,770
| -1% | -$26.7K |
2014 Q1
27 quarters
|
|
1157
Iridium Communications
IRDM
$4.71B
| $2.37M | 0.01% |
60,277
+1,066
| +2% | +$33.5K |
2014 Q1
27 quarters
|
|
1158
Novanta
NOVT
$5.32B
| $2.37M | 0.01% |
20,014
-51
| -0.3% | -$5.95K |
2017 Q2
14 quarters
|
|
1159
Highwoods Properties
HIW
$3.37B
| $2.36M | 0.01% |
59,548
-23,671
| -28% | -$855K |
2014 Q1
27 quarters
|
|
1160
HF Sinclair
DINO
$21.6B
| $2.35M | 0.01% |
90,970
-24,058
| -21% | -$545K |
2014 Q1
27 quarters
|
|
1161
Enovis
ENOV
$1.22B
| $2.35M | 0.01% |
35,736
-2,792
| -7% | -$163K |
2014 Q1
27 quarters
|
|
|
WDR
1162
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $2.35M | 0.01% |
92,218
+1,756
| +2% | +$33.8K |
2014 Q1
27 quarters
|
|
1163
Bath & Body Works
BBWI
$4.22B
| $2.35M | 0.01% |
78,057
-1,984
| -2% | -$57.6K |
2014 Q1
27 quarters
|
|
1164
California Water Service
CWT
$2.97B
| $2.34M | 0.01% |
43,293
+3,334
| +8% | +$164K |
2015 Q4
20 quarters
|
|
1165
DELISTED
WNS Holdings
WNS
| $2.33M | 0.01% |
32,352
+4,185
| +15% | +$281K |
2014 Q1
27 quarters
|
|
1166
Axalta
AXTA
$7.31B
| $2.33M | 0.01% |
81,515
-422
| -0.5% | -$11.5K |
2016 Q1
19 quarters
|
|
1167
Ultragenyx Pharmaceutical
RARE
$1.54B
| $2.32M | 0.01% |
16,791
+3,238
| +24% | +$384K |
2017 Q4
12 quarters
|
|
1168
Aramark
ARMK
$13.9B
| $2.32M | 0.01% |
83,513
+2,075
| +3% | +$49.7K |
2016 Q1
19 quarters
|
|
1169
Daqo New Energy
DQ
$690M
| $2.32M | 0.01% |
40,400
-435
| -1% | -$19K |
2020 Q1
3 quarters
|
|
1170
Four Corners Property Trust
FCPT
$2.43B
| $2.31M | 0.01% |
77,678
+7,334
| +10% | +$205K |
2015 Q4
20 quarters
|
|
1171
Portland General Electric
POR
$5.24B
| $2.31M | 0.01% |
54,057
+2,353
| +5% | +$95.9K |
2014 Q1
27 quarters
|
|
|
AVLR
1172
DELISTED
Avalara, Inc.
AVLR
| $2.3M | 0.01% |
13,968
+5,221
| +60% | +$835K |
2020 Q1
3 quarters
|
|
1173
Easterly Government Properties
DEA
$1.07B
| $2.3M | 0.01% |
40,674
-4,904
| -11% | -$269K |
2017 Q3
13 quarters
|
|
|
BBBY
1174
DELISTED
Bed Bath & Beyond Inc
BBBY
| $2.3M | 0.01% |
129,600
-1,253
| -1% | -$26K |
2014 Q1
27 quarters
|
|
1175
DELISTED
Diamond Hill
DHIL
| $2.3M | 0.01% |
15,391
+1,641
| +12% | +$239K |
2018 Q1
11 quarters
|
|
Similar funds
LCM
Aperio Group's Q4 2020 Portfolio in Review
As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
- Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
- Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
- Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
- Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
- Aperio Group opened 104 new positions and closed 53 in Q4 2020.
- Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.